Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

NASDAQ Composite (IXIC)

NASDAQ
Currency in USD
Disclaimer
16,349.25
+192.92(+1.19%)
Closed
Day's Range
16,197.8616,350.08
52 wk Range
12,174.0616,538.39
Prev. Close
16,156.33
Open
16,208.54
1-Year Change
32.05%
Volume
919,561,820
Average Vol. (3m)
1,067,380,922
Day's Range
16,197.86-16,350.08
52 wk Range
12,174.06-16,538.39
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
Type:Index
# Components:3355

People Also Watch

5,180.74
US500
+1.03%
18,093.57
NDX
+1.13%
13.49
VIX
0.00%
38,236.07
JP225
-0.10%
105.08
DXY
+0.05%
How do you feel today about IXIC?
Vote to see community's results!
or
NamePrice
E-mini NASDAQ Composite16,222.00+1.99%
NameVol.Price
ONEQ
Fidelity NASDAQ Composite
237.65K64.44+1.23%
NameVol.Price
LYRA
Lyra Therapeutics Inc
108.05M0.522-87.06%
NKLA
Nikola Corp
87.9M0.6374-3.06%
MARA
Marathon Digital Holdings Inc
86.6M20.67+17.98%
TSLA
Tesla Inc
83.4M184.76+1.97%
AAPL
Apple Inc
74.61M181.71-0.91%

Top Gainers

NamePrice
NUVO
Holdco Nuvo DG
5.25+3.21+157.35%
XBP
XBP Europe Holdings
3.50+1.380+65.09%
PLTN
Plutonian Acquisition
9.55+3.47+57.07%
PRFT
Perficient
73.26+25.15+52.28%
NRXP
NRX Pharmaceuticals
3.06+0.960+45.71%

Top Losers

NamePrice
LYRA
Lyra
0.522-3.509-87.06%
GLYC
GlycoMimetics
0.316-1.515-82.76%
EYPT
Eyepoint Pharma
11.20-8.540-43.26%
MMAT
Meta Materials
2.44-0.910-27.16%
AFIB
Acutus Medical
0.107-0.0377-26.05%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.